Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

A child's chronic use of Senna caused liver damage and a severe decrease in blood cells, but improved after stopping Senna and getting treatment.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Some drugs used to treat immune conditions may cause different types of hair loss.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

The conclusion is that certain physical signs in the body can indicate past acute and chronic stress, which may help in child abuse investigations.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Psychological stress and personal history are significant factors in hair loss.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

About 61% of women who had COVID-19 experienced hair loss afterward.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

TrichoScan accurately measures hair growth and showed improved hair counts and thickness after finasteride treatment.

Some medications can cause reversible hair loss by affecting hair growth cycles.

PRP is an effective and safe treatment for female hair loss.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Maintaining enough zinc may help prevent and manage hair loss.